Skip to content

DR. Jan Geiss

Active
Private limited companyfounded 2011active for 15 yearsVliegerlaan 15, 1170 Watermaal-Bosvoorde, BelgiumKBO/BCE: BE 0834.282.647
Summary

DR. Jan Geiss has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €135,645 and a net result of €122,645. Equity is shrinking by about 6.9% per year across the filed financial years. Its solvency ranks better than 81% of 39,121 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
DR. Jan GeissActiveChecked score 91/100
Risk analysis ReportCompare

Overview

Activity
Business and other management consultancy
NACE 70200
1 site
Size
€162,903total assets 2025
Equity
€135,645
Profit
€122,645
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
2025 accounts 9 days early1 of 2 deeds summarised
Why 91raises riskLiquidity: current ratio 3.31, cash €125, halvedlowers riskSector: Activities of head offices; management consultancy activities (NACE 70)Founded in 2011Equity €135,645 (83.3% of total assets)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 74% of its sector peers (NACE 70, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 100+67
equity 83.3% of total assets
Liquidity 46+28
short-term debt 16.7% · cash 0.1%
Profitability 100=
return on assets 75.3%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (48,416 companies, NACE 70, micro)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.3%▼ -0.1 percentage points vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.3 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €12,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.31, compared with 0.64 in 2024, above the usual 1.5; short-term debt: 16.7% and cash: 0.1% of total assets), and 16.7% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 70, micro): better than 86% on solvency, 26% on liquidity, 84% on profitability and 99% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 3.31, cash €125, halved
NBB · annual accounts
lowers risk · Sector: Activities of head offices; management consultancy activities (NACE 70)
KBO
lowers risk · Founded in 2011
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Equity €135,645 (83.3% of total assets)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €135,645
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-07-2026, 9 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
9 days early
2024
1 day early
2023
5 days early
2022
33 days early
2021
26 days late
2020
29 days early
2019
9 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days before the deadline; the sector median (NACE 70) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 27 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than 5 timescurrent ratio 3.31
  3. Equity above €100,000equity €135,645 ▲943%

Key points

  • Positive: Equity rose in 2025from €13,000 to €135,645 ▲ 943% View
  • Positive: Among the best 11% on net resultsector median €27,255 · 39,137 companies €122,645 View
  • Positive: 8 profitable years in a rowprofit 2025: €122,645 8 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Total assets
€162,903
Profit
€122,645
Solvency
83.3%
Total assets▲ 5.7%
Net result
20182025
Go to Financials

Timeline

Events
19
Since
2012
Next accounts
by 31-07-2027
  1. 30-07-2025Annual accounts filed
  2. 26-07-2024Annual accounts filed
  3. 11-09-2023Resignation: DR GEISS Jan Dieter (manager)
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Business and other management consultancyNACE 70200
Founded
04-03-2011
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
18
Who signs
Each director alone
Annual meeting
Last Friday of June at 18:00
Purpose
“La consultance en matière d’affaires politiques et publiques(et en particulier en ce qui…” (deed in French)
Go to Articles of association

Key facts about DR. Jan Geiss

What is the company number of DR. Jan Geiss?
0834.282.647. In Belgium the VAT number is the company number with BE in front: BE 0834.282.647.
Where is DR. Jan Geiss based?
The registered office is at Vliegerlaan 15, 1170 Watermaal-Bosvoorde.Company details
What does DR. Jan Geiss do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of DR. Jan Geiss?
Private limited company (BV).
When was DR. Jan Geiss founded?
On 04-03-2011.
Is DR. Jan Geiss still active?
Yes, DR. Jan Geiss is an active enterprise in the KBO register.
What is the turnover of DR. Jan Geiss?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR. Jan Geiss profitable?
In financial year 2025, DR. Jan Geiss made a profit of €122,645.
Where can I find the annual accounts of DR. Jan Geiss?
DR. Jan Geiss filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. Jan Geiss due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR. Jan Geiss

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure